Replies to post #8363 on Calmare Therapeutics Inc (fka CTTC)

[Vaffan-Coulo]

I have no idea whether Mr. Marineo was present. The abstract does indicate:

"We treated ten patients, 2 with cancer as their primary diagnosis, with refractory PHN Scrambler therapy at two institutions."

One might reasonably conclude that the other institution was in Italy since no one else's name is on the paper -- which is itself a curiosity in that physicians love getting their names on papers, so it's surprising that Smith is by himself on this one.

But that all misses the point -- the point being that no paper that doesn't have Mr. Marineo's name on it ever comes close to achieving the numbers presented in papers where his name is present. Perhaps his name is a good luck charm, and CTTC should start calling it "Marineo therapy" instead of "scrambler therapy."

Certainly, Mr. Marineo must have written the abstract given the quality of the writing -- "It can be debilitating and difficulty to treat," "treated ten patients...with refractory PHN Scrambler therapy," "without satisfactory relief despite conventional drugs."

But the real kicker is simply the numbers:

"...a 95% reduction, with continued relief at 2 and 3 months. Patients achieved maximum pain relief with less than 5 treatments."

I doubt whether there exists a treatment of any kind, anywhere, for anything that is able to effect a 95% relief of a symptom regardless of its etiology in nearly every patient regardless of background, much less with less than five treatments, even less so that would last two to three months. Most physicians probably find such numbers fall outside their range of "believability."

Add to that his claims elsewhere that he can do nearly the same with cirrhosis, scar removal, and reversing the effects of aging -- all using a similar (or perhaps the same) machine -- and a pattern emerges that could lead some to question just how real the numbers are.